Autologous Protein Solution (APS) and Osteoarthritis of the Knee: A Scoping Review of Current Clinical Evidence
In brief
This scoping review gathers clinical studies on autologous protein solution (APS), an injection concentrated from the patient’s own blood, for knee osteoarthritis. The included studies suggest it is safe and may reduce pain or improve function. The authors call for larger randomised trials against active treatments and real-world studies before regular use.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Autologous Protein Solution (APS) and Osteoarthritis of the Knee: A Scoping Review of Current Clinical Evidence Authors: Ashim Gupta Link: https://pubmed.ncbi.nlm.nih.gov/38449974/ Year of Publication: 2024
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

